[{"NetIncomeLoss_1_Q2_USD":-26353000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":2154000.0,"Depreciation_1_Q2_USD":100000.0,"Depreciation_2_Q2_USD":255000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":2347000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2_Q2_pure":0.012,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":8538000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"InterestPaidNet_2_Q2_USD":0.0,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":16000.0,"CommitmentsAndContingencies_0_Q2_USD":0.0,"RepaymentsOfLongTermDebt_2_Q2_USD":0.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":37583000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":37552000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":0.0,"GeneralAndAdministrativeExpense_1_Q2_USD":6268000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":214000.0,"OperatingLeaseExpense_2_Q2_USD":299000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":18.27,"OperatingLeaseRightOfUseAsset_0_Q2_USD":182000.0,"ShareBasedCompensation_2_Q2_USD":7990000.0,"Assets_0_Q2_USD":290523000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":3035000.0,"CommonStockSharesIssued_0_Q2_shares":37665000.0,"AssetsCurrent_0_Q2_USD":287309000.0,"ConversionOfStockAmountIssued1_2_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":208000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":98000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":5798.0,"LossContingencyAccrualAtCarryingValue_0_Q2_USD":0.0,"PrepaidExpenseAndOtherAssets_0_Q2_USD":7851000.0,"OperatingLeaseExpense_1_Q2_USD":149000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":3000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":12152000.0,"MarketableSecuritiesCurrent_0_Q2_USD":3035000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":430000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":151000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":188000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":579000.0,"CommonStockValue_0_Q2_USD":4000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":0.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":-2552000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-5000.0,"ProceedsFromStockPlans_2_Q2_USD":318000.0,"PaymentsOfFinancingCosts_2_Q2_USD":10000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":982000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":14.45,"ResearchAndDevelopmentExpense_1_Q2_USD":22706000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-2000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":3580000.0,"InvestmentIncomeNonoperating_2_Q2_USD":32000.0,"InvestmentIncomeNonoperating_1_Q2_USD":16000.0,"OperatingLeaseLiability_0_Q2_USD":964000.0,"Liabilities_0_Q2_USD":26043000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":381213000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":914000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":276423000.0,"OtherAssetsNoncurrent_0_Q2_USD":407000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-26350000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-50192000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_2_Q2_USD":0.0,"FairValueAdjustmentOfWarrants_1_Q2_USD":0.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":0.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":279500000.0,"DeferredCompensationLiabilityCurrent_0_Q2_USD":3303000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ResearchAndDevelopmentExpense_2_Q2_USD":43383000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":18000.0,"LiabilitiesCurrent_0_Q2_USD":16338000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":135000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-47816000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q2_USD":3000.0,"MarketableSecuritiesUnrealizedGainLoss_2_Q2_USD":5000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":4289000.0,"NonoperatingIncomeExpense_2_Q2_USD":27000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":0.0,"RestrictedCashNoncurrent_0_Q2_USD":251000.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"CommonStockSharesOutstanding_0_Q2_shares":37665000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-45039000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions_1_Q2_USD":9000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-116737000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":1857000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":5766000.0,"NonoperatingIncomeExpense_1_Q2_USD":14000.0,"InterestExpense_1_Q2_USD":0.0,"NetIncomeLoss_2_Q2_USD":-50197000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":2556000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_2_Q2_USD":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":94000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"OperatingLeasePayments_2_Q2_USD":0.0,"InterestExpense_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_2_Q2_USD":0.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":318000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":82000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_2_Q2_pure":0.005,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":276674000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.055,"ProceedsFromStockOptionsExercised_2_Q2_USD":122000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":0.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-69000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":3035000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":4497000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q2_USD":0.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_2_Q2_USD":0.0,"OperatingIncomeLoss_1_Q2_USD":-26367000.0,"OperatingIncomeLoss_2_Q2_USD":-50224000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":23.61,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_1_Q2_shares":38118.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":2607000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":5311000.0,"CommonStockSharesAuthorized_0_Q2_shares":400000000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":4394000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":220000.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_2_Q2_shares":48080.0,"PreferredStockValue_0_Q2_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":1.49,"LiabilitiesAndStockholdersEquity_0_Q2_USD":290523000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1233000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":8791000.0,"StockholdersEquity_0_Q2_USD":264480000.0,"ProfitLoss_2_Q2_USD":-50197000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.7,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.34,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":0.0,"OperatingExpenses_1_Q2_USD":28974000.0,"OperatingExpenses_2_Q2_USD":55535000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":50000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":4413000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":94000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":4289000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":7990000.0,"PreferredStockSharesAuthorized_0_Q2_shares":40000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":17.08,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":17000.0,"Ticker":"RNA","CIK":"1599901","name":"AVIDITY BIOSCIENCES, INC.","OfficialName":"Avidity Biosciences Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"872955496.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]